title: [Drug-induced esophagitis: can stringent indications help prevent this disease picture?].
authors.affiliation: Pharma Forschungszentrum, Bayer AG, Wuppertal.
authors.forename: T R
authors.initials: TR
authors.lastname: Weihrauch
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D019386:Alendronate / Q000008:administration & dosage / Q000009:adverse effects*; D004941:Esophagitis / Q000139:chemically induced* / Q000517:prevention & control; D005260:Female; D006801:Humans; D008875:Middle Aged; D010001:Osteitis Deformans / Q000188:drug therapy*; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D011358:Product Surveillance, Postmarketing; D012307:Risk Factors
chemical_list: D019386:Alendronate